Blomhotin
| Internal ID | 36a3321c-8db6-4c25-99d8-e30e5b8ef14c |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-1-[(2S)-1-[2-[[(2S)-1-[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C52H83N17O13/c1-3-29(2)41(49(80)68-25-8-14-34(68)44(75)63-32(50(81)82)12-5-21-58-52(55)56)64-45(76)35-15-7-24-67(35)47(78)36-16-9-22-65(36)40(72)28-60-43(74)33-13-6-23-66(33)48(79)37-17-10-26-69(37)46(77)31(11-4-20-57-51(53)54)62-39(71)27-59-42(73)30-18-19-38(70)61-30/h29-37,41H,3-28H2,1-2H3,(H,59,73)(H,60,74)(H,61,70)(H,62,71)(H,63,75)(H,64,76)(H,81,82)(H4,53,54,57)(H4,55,56,58)/t29-,30-,31-,32-,33-,34-,35-,36-,37-,41-/m0/s1 |
| InChI Key | PKFRTKLTOXCPMQ-VBIYNZGFSA-N |
| Popularity | 6 references in papers |
| Molecular Formula | C52H83N17O13 |
| Molecular Weight | 1154.30 g/mol |
| Exact Mass | 1153.63562577 g/mol |
| Topological Polar Surface Area (TPSA) | 442.00 Ų |
| XlogP | -3.70 |
| Atomic LogP (AlogP) | -4.86 |
| H-Bond Acceptor | 14 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 26 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7387 | 73.87% |
| Caco-2 | - | 0.8563 | 85.63% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.6286 | 62.86% |
| Subcellular localzation | Lysosomes | 0.4823 | 48.23% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8301 | 83.01% |
| OATP1B3 inhibitior | + | 0.9397 | 93.97% |
| MATE1 inhibitior | - | 0.8000 | 80.00% |
| OCT2 inhibitior | - | 0.6000 | 60.00% |
| BSEP inhibitior | + | 0.9410 | 94.10% |
| P-glycoprotein inhibitior | + | 0.7428 | 74.28% |
| P-glycoprotein substrate | + | 0.8111 | 81.11% |
| CYP3A4 substrate | + | 0.7059 | 70.59% |
| CYP2C9 substrate | + | 0.5936 | 59.36% |
| CYP2D6 substrate | - | 0.8620 | 86.20% |
| CYP3A4 inhibition | - | 0.9738 | 97.38% |
| CYP2C9 inhibition | - | 0.8812 | 88.12% |
| CYP2C19 inhibition | - | 0.8645 | 86.45% |
| CYP2D6 inhibition | - | 0.9283 | 92.83% |
| CYP1A2 inhibition | - | 0.9034 | 90.34% |
| CYP2C8 inhibition | + | 0.5355 | 53.55% |
| CYP inhibitory promiscuity | - | 0.9960 | 99.60% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.5989 | 59.89% |
| Eye corrosion | - | 0.9866 | 98.66% |
| Eye irritation | - | 0.8966 | 89.66% |
| Skin irritation | - | 0.7621 | 76.21% |
| Skin corrosion | - | 0.9212 | 92.12% |
| Ames mutagenesis | - | 0.6600 | 66.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6522 | 65.22% |
| Micronuclear | + | 0.7400 | 74.00% |
| Hepatotoxicity | - | 0.5470 | 54.70% |
| skin sensitisation | - | 0.8706 | 87.06% |
| Respiratory toxicity | + | 0.6889 | 68.89% |
| Reproductive toxicity | + | 0.7667 | 76.67% |
| Mitochondrial toxicity | + | 0.6000 | 60.00% |
| Nephrotoxicity | - | 0.8229 | 82.29% |
| Acute Oral Toxicity (c) | III | 0.6048 | 60.48% |
| Estrogen receptor binding | + | 0.7477 | 74.77% |
| Androgen receptor binding | + | 0.7174 | 71.74% |
| Thyroid receptor binding | + | 0.5928 | 59.28% |
| Glucocorticoid receptor binding | + | 0.5894 | 58.94% |
| Aromatase binding | + | 0.7180 | 71.80% |
| PPAR gamma | + | 0.6849 | 68.49% |
| Honey bee toxicity | - | 0.8148 | 81.48% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.6600 | 66.00% |
| Fish aquatic toxicity | - | 0.5170 | 51.70% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.84% | 98.95% |
| CHEMBL204 | P00734 | Thrombin | 99.76% | 96.01% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.07% | 89.63% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.70% | 96.09% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.97% | 98.33% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.81% | 100.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 97.18% | 90.71% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.53% | 96.47% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.18% | 94.45% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.04% | 94.66% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 94.51% | 98.24% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 94.41% | 97.50% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 93.85% | 98.10% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 93.82% | 99.52% |
| CHEMBL4608 | P33032 | Melanocortin receptor 5 | 93.63% | 97.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.60% | 97.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.54% | 91.11% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 93.45% | 95.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.04% | 97.64% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 92.70% | 95.52% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 92.58% | 82.69% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.58% | 99.17% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 90.87% | 93.56% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 90.60% | 99.18% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 90.60% | 100.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 90.36% | 99.35% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 90.36% | 96.67% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 90.20% | 96.38% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 89.60% | 94.05% |
| CHEMBL3837 | P07711 | Cathepsin L | 89.21% | 96.61% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.88% | 95.89% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.88% | 93.00% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 87.50% | 90.00% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 87.34% | 97.79% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.09% | 96.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 87.05% | 100.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 87.02% | 96.67% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 86.98% | 95.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.85% | 98.59% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 86.80% | 96.03% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 86.45% | 94.45% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 85.94% | 90.65% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.77% | 95.56% |
| CHEMBL3691 | Q13822 | Autotaxin | 85.72% | 96.39% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 85.18% | 90.17% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 85.06% | 94.00% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 84.81% | 98.77% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 84.77% | 91.19% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.74% | 97.50% |
| CHEMBL5028 | O14672 | ADAM10 | 84.50% | 97.50% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 84.31% | 93.33% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 83.83% | 90.24% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 83.78% | 90.08% |
| CHEMBL3105 | P09874 | Poly [ADP-ribose] polymerase-1 | 83.44% | 93.90% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 83.37% | 82.50% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 83.28% | 92.38% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 83.04% | 96.25% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 82.56% | 92.88% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 82.19% | 96.21% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.89% | 88.56% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.84% | 95.36% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 81.64% | 95.38% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.45% | 100.00% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.12% | 93.03% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.05% | 94.33% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 81.02% | 96.76% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.78% | 82.38% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 80.64% | 93.10% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 80.59% | 99.23% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 80.01% | 80.71% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101037291 |
| LOTUS | LTS0260477 |
| wikiData | Q105210394 |